Minocycline and bone marrow–derived mononuclear cells as potential therapeutics for hereditary retinal degenerations
Acta Ophthalmologica · 2026-09 · 104 (6)
DOI: 10.1111/aos.70108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Ophthalmologica, online erschienen am 10.03.2026. Verfasst von Alba Videla-Ristol und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, Murcia, Spain. Hauptthemen laut MEDLINE: Minocycline, Retinal Degeneration, Bone Marrow Transplantation. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, MCIN/AEI, NextGenerationEU.
Abstract (Originalsprache)
Purpose
To assess in Royal College of Surgeons ( RCS ) rats if the combination of two previously documented neuroprotective strategies: minocycline administration and bone marrow–derived mononuclear cells ( BM ‐ MNCs ) intravitreal transplantation, offers enhanced neuroprotection compared with each treatment alone.
Methods
Forty‐eight homozygous pigmented RCS rats were divided into four groups: control, intravitreal BM‐MNC transplantation, systemic minocycline treatment or combined therapy. Treatments were administered at postnatal day (P) 27–28. Animals were evaluated in vivo by spectral domain optical coherence tomography (SD‐OCT) at P28, P35 and P51. Retinal sections were analysed for photoreceptor survival (outer nuclear layer [ONL] cell counts), synaptic preservation (Bassoon immunoreactivity), microglial activation (Iba‐1+ cells) and macroglial reactivity (glial fibrillary acidic protein [GFAP] expression).
Results
Both BM‐MNC and minocycline monotherapies significantly preserved total and outer retinal thicknesses and increased ONL nuclei counts compared with controls. Combined treatment yielded superior protection at both P35 and P51. Minocycline alone or in combination significantly reduced microglial cell activation, while BM‐MNCs alone or in combination significantly reduced GFAP expression. Synaptic integrity in the outer plexiform layer, assessed via Bassoon labelling, was significantly better preserved in treated animals, with the highest levels observed in the combined therapy group.
Conclusions
Minocycline and BM‐MNCs provide complementary neuroprotective effects in the RCS rat model. While minocycline reduces microglial activation, BM‐MNCs modulate macroglial response. Their combination enhances photoreceptor survival and synaptic preservation more effectively than either treatment alone. These findings support the therapeutic potential of combining pharmacological and cell‐based interventions in hereditary retinal degenerations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, Murcia, Spain.
- Instituto Murciano de Investigación Biosanitaria-Virgen de la Arrixaca Pascual Parrilla (IMIB-Arrixaca), Murcia, Spain.
- Departamento de Bioquímica, Biología Molecular B e Inmunología, Facultad de Medicina, Universidad de Murcia, Murcia, Spain.
ORCID-Profile: David García-Bernal, Manuel Vidal-Sanz, María Paz Villegas-Pérez, Diego García-Ayuso, Johnny Di Pierdomenico
Förderung
- Instituto de Salud Carlos III
- MCIN/AEI
- NextGenerationEU
- FUNDACION SÉNECA - AGENCIA DE CIENCIA Y TECNOLOGÍA DE LA REGIÓN DE MURCIA - GERM (Ayudas a Grupos de Investigación de Excelencia de la Región de Murcia)
Zitieren
APA
Videla-Ristol, A., Martínez-Vacas, A., García-Bernal, D., Vidal-Sanz, M., Villegas-Pérez, M. P., García-Ayuso, D., & Di Pierdomenico, J. (2026). Minocycline and bone marrow–derived mononuclear cells as potential therapeutics for hereditary retinal degenerations. Acta Ophthalmologica, 104(6). https://doi.org/10.1111/aos.70108
Vancouver
Videla-Ristol A, Martínez-Vacas A, García-Bernal D, Vidal-Sanz M, Villegas-Pérez MP, García-Ayuso D, et al. Minocycline and bone marrow–derived mononuclear cells as potential therapeutics for hereditary retinal degenerations. Acta Ophthalmologica. 2026;104(6). doi:10.1111/aos.70108
BibTeX
@article{VidelaRistol2026,
author = {Videla-Ristol, Alba and Martínez-Vacas, Ana and García-Bernal, David and Vidal-Sanz, Manuel and Villegas-Pérez, María Paz and García-Ayuso, Diego and Di Pierdomenico, Johnny},
title = {Minocycline and bone marrow–derived mononuclear cells as potential therapeutics for hereditary retinal degenerations},
journal = {Acta Ophthalmologica},
year = {2026},
volume = {104},
number = {6},
doi = {10.1111/aos.70108}
}
EUVIMED